World Schizophrenia Global Market Surging With a Striking CAGR of 3.2% by 2023

Schizophrenia Market
Schizophrenia Market Information: By Diagnosis (Blood and Urine Tests, Brain Imaging, and Vision Testing), Treatment Type (Surgery, Radiation Therapy, and Medications), End User (Hospitals, Clinics, and Diagnostic Centers) – Global Forecast till 2023

Market Highlights

Schizophrenia is a chronic and severe mental disorder that affects the thinking, feeling, and behavior of the person. People with schizophrenia may be more in imagination world and lost touch with reality. Although schizophrenia is not as common as other mental disorders, the symptoms can be very disabling. The symptoms of this disease are categories in three way that are positive, negative, and cognitive. The global Schizophrenia Market is expected to grow at a CAGR of 3.2% during the forecast period 2017-2023.

People with schizophrenia are more prone to die earlier than the normal population. This is often due to physical illnesses, such as cardiovascular, metabolic and infectious diseases. According to WHO, in 2016, More than 50% of people with schizophrenia are not receiving appropriate care. 90% of people with untreated schizophrenia live in low and developing countries, such as India, Pakistan, etc.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/1625 .

Increasing prevalence of patients seeking treatment and rising demand for improved healthcare infrastructure are expected to drive the market. Moreover availability of funds and WHO initiative towards developing countries fuel the market in developing region.

Key Players

Some of key the players in the market are Minerva Neurosciences (U.S.), Promentis Pharmaceuticals, Inc. (U.S.), Bristol-Myers Squibb (U.S.), PsychoGenics Inc. (U.S.), Vineuro Pharmaceuticals, Novartis AG (Switzerland), Merz Pharma GmbH & Co. KGaA (Germany), AbbVie Inc. (U.S.), Eli-Lilly and Company (U.S.), AstraZeneca Plc. (U.K)

Regional Analysis:

The Americas dominate the global schizophrenia market owing to the presence of awareness of healthcare, high healthcare spending, and increasing government support for research & development.  

Europe holds the second largest share of the global schizophrenia market as result of increasing focus of various government agencies on the treatment of mental illness disease such as schizophrenia. Moreover, the growing public awareness about schizophrenia likely to boost the Europe market.

Asia Pacific is the fastest growing schizophrenia market across the globe. Moreover, rapidly developing economy, increasing healthcare expenditure, and the government’s initiatives for research & development projected to drive the market in India, Iran, Pakistan, Tanzania, over the forecasted period. Additionally, WHO initiative for training primary health-care personnel, providing access to essential drugs, and supporting families in providing home care lead the market growth of the schizophrenia in the region.

The Middle East and Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market.

Order Single User License Copy of 115 Premium Pages is Available @ https://www.marketresearchfuture.com/reports/schizophrenia-market-1625 .

Segmentation:

The global schizophrenia market is segmented on the basis of by diagnosis, by treatment type, and by end user. On the basis of the diagnosis, it is segmented into blood and urine tests, brain imaging, vision testing, and others. On the basis of the treatment type, it is segmented into surgery, radiation therapy, medications, and others. On the basis of the end user, it is segmented into hospitals, clinics, diagnostic centers, rehabilitation centers and others.

Brief TOC

1.    Report Prologue    

2.    Market Introduction    

      2.1    Definition    
      2.2    Scope of the Study    
            2.2.1    Research Objective    
            2.2.2    Assumptions    
            2.2.3    Limitations    

3.    Research Methodology

      3.1    Introduction
      3.2    Primary Research    
      3.3    Secondary research    
      3.4    Market Size Estimation

4.    Market Dynamics

      4.1    Drivers    
      4.2    Restrains
      4.3    Opportunities    
      4.4    Challenges
      4.5    Macroeconomic Indicators
      4.6    Technology Trends & Assessment            

5.    Market Factor Analysis

…. TOC Continued

Ask to Expert @ https://www.marketresearchfuture.com/enquiry/1625 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/schizophrenia-market-1625